Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
09/2013
09/18/2013CN102771861B Functional drink recipe for preventing three-high, fat and inner fire and manufacturing method of functional drink recipe for preventing three-high, fat and inner fire
09/18/2013CN102676349B Giant salamander bone healthcare wine and preparation method thereof
09/18/2013CN102631633B Preparation method for traditional Chinese medicine wash lotion for treating constipation type acute lymphangitis
09/18/2013CN102631355B Medicine composite containing aspirin and application thereof
09/18/2013CN102579644B Compound Chinese hawthorn leaf total flavone dripping pill and preparation method thereof
09/18/2013CN102399262B Tripeptides with angiotensin converting enzyme inhibition activity and their use and composition
09/18/2013CN102336701B Carvedilol sulphate crystals, preparation method and application thereof in medicine
09/18/2013CN102320956B Sodium ferulate composition freeze-dried powder injection and preparation method thereof
09/18/2013CN102302635B Traditional Chinese medicine for treating haemorrhoids, chilblain and pressure sore and preparation method thereof
09/18/2013CN102247356B Use of andrographolides, dehydrated andrographolides, new andrographolides and deoxidized andrographolides
09/18/2013CN102229911B Sca-1+/CD34- uterine stem cells and separation method thereof
09/18/2013CN102091055B Calcium dobesilate capsule and preparation method thereof
09/18/2013CN102060889B Stilbene glycoside derivative
09/18/2013CN101926798B Dispersible tablet containing amlodipine and valsartan
09/18/2013CN101848717B Use of norgestimate as a selective inhibitor of trpc3, trpc6 and trpc7 ion channels
09/18/2013CN101829120B Composition for treatment of external secretion disorders
09/18/2013CN101413143B Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
09/18/2013CN101325964B Vip片段和应用方法 Vip fragments and application methods
09/18/2013CN101293831B Uses of 3-hydroxy fatty acid and its derivative in preparing calcium ion duct modifying agent
09/17/2013US8536216 Compositions based on aminoacids
09/17/2013US8536184 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof
09/17/2013US8536160 Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders
09/17/2013US8536117 Oxidant resistant apolipoprotein A-1 and mimetic peptides
09/17/2013US8535899 Assay for identifying a modulator of HIF hydroxylase
09/17/2013US8535715 Bilayer tablet formulations
09/17/2013CA2529318C Methods of inhibiting vascular permeability and apoptosis
09/17/2013CA2451738C Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals using 2-amino-2'-deoxyadenosine
09/12/2013WO2013134660A1 4 -hydroxy- isoquinoline compounds as hif hydroxylase inhibitors
09/12/2013WO2013134353A1 Fused bicyclic 2,4-diaminopyrimidine derivative as a dual alk and fak inhibitor
09/12/2013WO2013134226A1 Benzodioxanes for inhibiting leukotriene production
09/12/2013WO2013133677A1 Composition containing reaction mixture of red-ginseng extract and persimmon vinegar for preventing or treating vascular diseases
09/12/2013WO2013133325A1 Tricyclic compound
09/12/2013WO2013133217A1 Glucose uptake promoter
09/12/2013WO2013133032A1 Dipeptidyl peptidase-iv inhibitor
09/12/2013WO2013133031A1 Dipeptidyl peptidase-iv inhibitor
09/12/2013WO2013132668A1 Composition comprising imidazole peptide and quercetin glycoside
09/12/2013WO2013132509A1 Novel compounds for the treatment of dyslipidemia and related diseases
09/12/2013WO2013131923A1 Substituted azabicycles and use thereof
09/12/2013WO2013131901A1 Benzodioxanes in combination with other actives for inhibiting leukotriene production
09/12/2013WO2013131270A1 Scutellarin hydrate and preparation method and use thereof
09/12/2013WO2013112959A8 Antifibrotic compounds and uses thereof
09/12/2013US20130239234 Phosphodiesterase activity and regulation of phosphodiesterase 1b-mediated signaling in brain
09/12/2013US20130237696 Vascular therapeutics
09/12/2013US20130237588 Vascular therapeutics
09/12/2013US20130236498 Biodegradable supporting device
09/11/2013EP2636412A2 Composition for dissolving thrombi, and a pharmaceutical composition for treating stenotic or occlusive vascular diseases which comprises the same
09/11/2013EP2636408A1 Patch
09/11/2013EP2635577A1 Substituted 6-fluoro-1h-pyrazolo[4,3-b]pyridines and use thereof
09/11/2013EP2635576A1 Benzyl-substituted carbamates and use thereof
09/11/2013EP2635573A1 Heterocyclic compounds as s1p1 agonists for the treatment of autoimmune and vascular diseases
09/11/2013EP2635566A1 Benzimidazole inhibitors of leukotriene production
09/11/2013EP2635562A1 Pyrrolidine derivatives used as cathepsin inhibitors
09/11/2013EP2635283A2 Methods for treatment of brain injury utilizing biologics
09/11/2013EP2635281A1 Methods and compositions for prevention and treatment of cardiac hypertrophy
09/11/2013EP2635275A1 Gpr17-modulating compounds, diagnostic and therapeutic uses thereof
09/11/2013EP2635270A1 Methods of treatment using lipid compounds
09/11/2013EP2635268A1 Pharmaceutical combinations for the treatment of metabolic disorders
09/11/2013CN1665807B Novel physiolgically active substances
09/11/2013CN103298807A Heterocyclic compounds as S1P1 agonists for the treatment of autoimmune and vascular diseases
09/11/2013CN103298796A Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio) acetic acid and uses thereof
09/11/2013CN103298488A Peptide or peptide complex binding to 2 integrin and methods and uses involving the same
09/11/2013CN103298465A Uses of cimiracemate and related compounds for treating inflammation and modulating immune responses
09/11/2013CN103293316A A method of diagnosis and treatment
09/11/2013CN103289980A Protease screening methods and proteases indentified thererby
09/11/2013CN103288918A Small peptide with dual inhibitory activity against renin and ACE, and applications thereof
09/11/2013CN103288913A Novel compound, pharmaceutical compositions thereof as well as preparation methods thereof and use of novel compound and pharmaceutical compositions
09/11/2013CN103288833A Imidazo triazines and imidazo pyrimidines as kinase inhibitors
09/11/2013CN103288820A Compound 13-methyl-palmatrubine and application thereof
09/11/2013CN103288815A Beta-lactamyl vasopression V1a antagonists
09/11/2013CN103288793A Phenethanolamine derivatives for treatment of respiratory diseases
09/11/2013CN103288745A 2,6-disubstituted pyridazinone compound and application thereof
09/11/2013CN103288721A (4-(4-[6-(trifluoromethyl-pyridin-3-ylamino)-n-containing-heteroaryl]-phenyl)-cyclohexyl)-acetic acid derivatives and pharmaceutical uses thereof
09/11/2013CN103288715A Carvedilol phosphate salts and/or solvates thereof, correspondinq compositions, and/or methods of treatment
09/11/2013CN103288714A Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment
09/11/2013CN103288664A Novel BAPTA derivative, preparation method thereof and medicinal use thereof
09/11/2013CN103285406A MicroRNA-203, and application of analogue thereof in preparation of medicament for preventing and treating obesity, dyslipidemia and complication of obesity and dyslipidemia
09/11/2013CN103285402A New application of polyethylene glycol and pigment epithelium derived growth factor conjugate
09/11/2013CN103285383A Pharmaceutical composition comprising bromelain and bromelain enteric-coated tablet
09/11/2013CN103285380A Novel application of insulin to myocardial preservation
09/11/2013CN103285379A Use of GLP-1 (Glucagon-Like Peptide-1) for preparing medicines for preventing and treating macrovascular complications of type 2 diabetes
09/11/2013CN103285378A Use of GLP-1 (Glucagon-Like Peptide-1) for preparing medicines for preventing and treating type 2 diabetic cardiomyopathy
09/11/2013CN103285375A Phycocyanin microsphere preparation and preparation method thereof
09/11/2013CN103285372A Cerebroprotein hydrolysate and injection preparation thereof
09/11/2013CN103285369A Traditional Chinese medicine composition for treating heart failure
09/11/2013CN103285360A Traditional Chinese medicinal preparation for treating thromboangiitis obliterans, and preparation method thereof
09/11/2013CN103285328A Traditional Chinese medicine composition capsule for treating coronary heart diseases and preparation method thereof
09/11/2013CN103285327A Traditional Chinese medicine composition tablet for treating coronary heart diseases and preparation method thereof
09/11/2013CN103285324A Medicine composition for treating phlebitis
09/11/2013CN103285322A Traditional Chinese medicine composition for treating hypertrophic cardiomyopathy
09/11/2013CN103285306A Preparation method and detection method of traditional Chinese medicine composition for benefiting Qi and tonifying kidney
09/11/2013CN103285295A Traditional Chinese medicine preparation
09/11/2013CN103285288A Medicament for treating chronic cardiac insufficiency
09/11/2013CN103285278A Medicament for preventing and treating ischemic cerebral apoplexy and preparation method thereof
09/11/2013CN103285275A Medicament for preventing and treating atherosclerosis and preparation method thereof
09/11/2013CN103285241A Traditional Chinese medicine composition for treating hypertrophic cardiomyopathy and application method thereof
09/11/2013CN103285240A Dendrobium Panax quinquefolius buccal tablet and its preparation method
09/11/2013CN103285229A Tea for treating heart diseases
09/11/2013CN103285220A Traditional Chinese medicine for treating hypertension
09/11/2013CN103285189A Chinese medicine preparation for treating angina
09/11/2013CN103285181A Traditional Chinese medicine composition for treating qi-stagnation and blood stasis type haemorrhoids
1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 1595